(-0.14%) 5 461.38 points
(-0.34%) 38 980 points
(0.21%) 17 754 points
(0.32%) $81.09
(-3.48%) $2.66
(-0.97%) $2 308.20
(-0.34%) $28.77
(1.48%) $1 001.00
(0.27%) $0.936
(0.80%) $10.69
(0.36%) $0.791
(-0.59%) $86.98
Live Chart Being Loaded With Signals
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs...
Stats | |
---|---|
本日の出来高 | 62 734 |
平均出来高 | 84 624 |
時価総額 | 356.56M |
EPS | $-0.380 ( Q2 | 2024-04-30 ) |
Last Dividend | $0.130 ( 2015-02-02 ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.182 (2.25%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-30 | Bryce Richard Paul | Buy | 153 000 | Stock Option (Right to Buy) |
2023-11-30 | Daws D. Ryan | Buy | 232 000 | Stock Option (Right to Buy) |
2023-11-27 | Daws D. Ryan | Buy | 0 | |
2023-10-31 | Forbion Capital Fund Iii Cooperatief U.a. | Sell | 0 | Class A common shares |
2023-11-30 | Forbion Capital Fund Iii Cooperatief U.a. | Sell | 475 076 | Warrant (Right to Buy) |
INSIDER POWER |
---|
-38.61 |
Last 15 transactions |
Buy: 475 436 | Sell: 921 648 |
ボリューム 相関
enGene Holdings Inc. 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
enGene Holdings Inc. 相関 - 通貨/商品
enGene Holdings Inc. 財務諸表
Annual | 2022 |
収益: | $0 |
総利益: | $0 (0.00 %) |
EPS: | $0 |
FY | 2022 |
収益: | $0 |
総利益: | $0 (0.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
enGene Holdings Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.180 | 2012-04-02 |
Last Dividend | $0.130 | 2015-02-02 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | $2.52 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
Unable to generate commentary due to missing data.
Ex Date | Amount | Declaration Date | Record Date | Payment Date |
---|---|---|---|---|
02 Feb 2015 | $0.130 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
01 Dec 2014 | $0.140 | 01 Dec 2014 | 30 Nov -0001 | 05 Dec 2014 |
03 Nov 2014 | $0.150 | 03 Nov 2014 | 30 Nov -0001 | 07 Nov 2014 |
01 Oct 2014 | $0.150 | 01 Oct 2014 | 30 Nov -0001 | 07 Oct 2014 |
01 May 2014 | $0.130 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
02 Dec 2013 | $0.120 | 29 Nov 2013 | 30 Nov -0001 | 06 Dec 2013 |
01 Nov 2013 | $0.120 | 01 Nov 2013 | 30 Nov -0001 | 07 Nov 2013 |
01 Oct 2013 | $0.120 | 01 Oct 2013 | 30 Nov -0001 | 07 Oct 2013 |
01 Aug 2013 | $0.120 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
01 May 2013 | $0.120 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
26 Dec 2012 | $0.110 | 30 Nov -0001 | 30 Nov -0001 | 30 Nov -0001 |
03 Dec 2012 | $0.110 | 03 Dec 2012 | 30 Nov -0001 | 07 Dec 2012 |
01 Nov 2012 | $0.120 | 01 Nov 2012 | 30 Nov -0001 | 07 Nov 2012 |
01 Oct 2012 | $0.120 | 01 Oct 2012 | 30 Nov -0001 | 05 Oct 2012 |
04 Sep 2012 | $0.120 | 04 Sep 2012 | 30 Nov -0001 | 10 Sep 2012 |
01 Aug 2012 | $0.120 | 01 Aug 2012 | 30 Nov -0001 | 07 Aug 2012 |
02 Jul 2012 | $0.110 | 02 Jul 2012 | 30 Nov -0001 | 09 Jul 2012 |
01 Jun 2012 | $0.110 | 01 Jun 2012 | 30 Nov -0001 | 07 Jun 2012 |
01 May 2012 | $0.120 | 01 May 2012 | 30 Nov -0001 | 07 May 2012 |
02 Apr 2012 | $0.180 | 02 Apr 2012 | 30 Nov -0001 | 09 Apr 2012 |
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Diamond | 2024-09-16 | Monthly | 14 | 15.03% | 9.60 |
DMLP | Dividend Diamond | 2024-04-26 | Quarterly | 22 | 10.71% | 9.35 |
OXSQ | Dividend Diamond | 2024-09-16 | Monthly | 21 | 12.73% | 9.02 |
ARLP | Dividend Royal | 2024-05-07 | Quarterly | 26 | 9.67% | 8.87 |
PNNT | Dividend Royal | 2024-06-14 | Monthly | 18 | 9.49% | 8.82 |
MFIC | Dividend Royal | 2024-06-11 | Quarterly | 21 | 10.89% | 8.79 |
SPOK | Dividend Royal | 2024-05-23 | Quarterly | 20 | 8.73% | 8.72 |
PSEC | Dividend Royal | 2024-06-25 | Monthly | 21 | 9.03% | 8.65 |
SBLK | Dividend Royal | 2024-06-06 | Quarterly | 17 | 13.10% | 8.63 |
GBDC | Dividend Royal | 2024-11-29 | Bi-Monthly | 15 | 8.53% | 8.62 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0 | 1.500 | 0 | 0 | [0 - 0.5] |
returnOnAssetsTTM | -0.413 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -1.591 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 42.80 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 42.23 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 42.04 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0902 | -1.500 | 8.50 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -11.50 | 1.000 | -5.37 | -5.37 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.903 | 2.00 | -0.301 | -0.602 | [0 - 30] |
freeCashFlowPerShareTTM | -0.928 | 2.00 | -0.464 | -0.928 | [0 - 20] |
debtEquityRatioTTM | 0.102 | -1.500 | 9.59 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0 | 1.000 | -3.33 | -3.33 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0 | 1.000 | -2.00 | -2.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -1.443 | 1.000 | -9.13 | -9.13 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 0.0973 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -2.83 | 1.000 | -0.387 | 0 | [1 - 100] |
returnOnEquityTTM | -1.591 | 2.50 | -10.00 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.928 | 2.00 | -0.309 | -0.928 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.903 | 2.00 | -0.301 | -0.602 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0283 | 1.500 | -3.52 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0 | 1.000 | -2.50 | 0 | [0.1 - 0.5] |
Total Score | -1.939 |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
enGene Holdings Inc.
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。